Get started
Author

Miles C. Braithwaite

Observed names: Braithwaite, Miles, M Braithwaite, M. Braithwaite, M.C. Braithwaite
OpenAlex ID: A5113657023
Nutraceutical-based therapeutics and formulation strategies augmenting their efficiency to complement modern medicine: An overview
2013 · Miles C. Braithwaite, Charu Tyagi, et al. · Journal of Functional Foods · 171
Validation of smoke inhalation therapy to treat microbial infections
2008 · M. Braithwaite, S.F. Van Vuuren, et al. · Journal of Ethnopharmacology · 55
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
A novel multi-tiered experimental approach unfolding the mechanisms behind cyclodextrin-vitamin inclusion complexes for enhanced vitamin solubility and stability
2017 · Miles C. Braithwaite, Pradeep Kumar, et al. · International Journal of Pharmaceutics · 30
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2024 · RECOVERY Collaborative Group, Peter Sandercock, et al. · Nature Communications · 11
PDF
Vitamin D therapy and related metabolomics: Is the calciferol dose and form the only requirements for successful clinical therapeutics?
2013 · M.C. Braithwaite, P. Kumar, et al. · Medical Hypotheses · 9
A novel bile salts–lipase polymeric film-infused minitablet system for enhanced oral delivery of cholecalciferol
2015 · Miles C. Braithwaite, Yahya E. Choonara, et al. · Pharmaceutical Development and Technology · 6
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5
A laboratory model for studying inhalation therapy in traditional healing rites
2008 · M. Braithwaite · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · 3
PDF
Biopolymeric archetypes for the oral delivery of nutraceuticals
2016 · Mershen Govender, Miles C. Braithwaite, et al. · 2
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases
PDF
A Bioactive Association Platform Delivery System for Enhanced Efficacy of Pharmaceutical Products
2015 · Braithwaite, Miles
Works count: 14
Citation count: 384
H-index: 8
I10-index: 7
Year
Topic
Type